Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A.
BACKGROUND
Temporomandibular disorder (TMD) and chronic tension headaches clinically coexist in many individuals. Generally considered as separate pathological entities, they have been clinically treated by different means.


OBJECTIVE
To determine the utility of treatment with botulinum toxin for patients with coexisting TMD and chronic tension type headache.


METHODS
In this open-label study of 60 subjects with chronic TMD, 46 subjects also met the diagnostic criteria for chronic tension headache. All 60 subjects were treated with 150 units of botulinum toxin-A injected into the masticatory muscles, specifically 50 units into each masseter and 25 units into each temporalis muscle.


RESULTS
Thirty-eight of 60 subjects (63%) reported a 50% improvement in their facial pain during the follow-up period. The subset of 46 subjects with chronic tension headache and TMD symptoms reported a 50% or greater improvement in headache pain as well. The number of headache free days also improved postinjection.


CONCLUSIONS
These results suggest that the masticatory muscles, specifically the temporalis, may be involved in the pathogenesis of this form of chronic tension headache found in association with TMD.
Freund
Brian J
BJ
brian.freund@utoronto.ca
Schwartz
Marvin
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011446:Prospective Studies; D013705:Temporomandibular Joint Disorders / Q000150:complications / Q000188:drug therapy*; D018781:Tension-Type Headache / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A